TEAM.NASDAQAtlassian CORP

Form 4: Atlassian Co-CEO Michael Cannon-Brookes Executes Stock Sales Under 10b5-1 Trading Plan

Sentiment:

SEC Form 4 Filing


Michael Cannon-Brookes, Co-CEO and Co-Founder of Atlassian, reports multiple sales of Class A Common Stock executed on February 28, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • Michael Cannon-Brookes, Co-CEO and Co-Founder of Atlassian, filed a Form 4 disclosing sales of Atlassian Class A Common Stock on February 28, 2024.
  • The sales were executed under a Rule 10b5-1 trading plan adopted on February 21, 2023.
  • The transactions involved multiple sales at varying prices, ranging from approximately $202.24 to $208.29 per share.
  • Cannon-Brookes sold shares both directly and indirectly through a trust (CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust).
  • The total number of shares sold directly was 7,721.
  • The sales resulted in a decrease in the number of shares beneficially owned indirectly by the trust.
  • Following the reported transactions, the trust beneficially owns 173,061 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document primarily reports stock sales under a pre-arranged trading plan, which doesn't necessarily indicate a positive or negative outlook.

Risks

  • Executive stock sales can sometimes be perceived negatively by investors, potentially impacting the stock price, although sales under a 10b5-1 plan are generally viewed as less concerning.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies. Monitoring these transactions provides insights into management's perspective on the company's valuation and future prospects. Sales under 10b5-1 plans are less likely to be driven by immediate market sentiment.

Stakeholder Impact

  • The stock sales could have a minor impact on shareholders, potentially causing a slight decrease in stock price due to increased supply, although the impact is likely to be minimal given the pre-planned nature of the sales.

Key Dates

DateDescription
02/21/2023Date the Reporting Person adopted the Rule 10b5-1 trading plan
02/28/2024Date of the stock sale transactions
02/29/2024Date of the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.